137 related articles for article (PubMed ID: 2076571)
1. Synthesis of 2-[[(4-fluoroalkoxy-2-pyridyl)methyl]sulfinyl]-1H- benzimidazoles as antiulcer agents.
Kubo K; Oda K; Kaneko T; Satoh H; Nohara A
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2853-8. PubMed ID: 2076571
[TBL] [Abstract][Full Text] [Related]
2. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
3. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
[TBL] [Abstract][Full Text] [Related]
4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Nagaya H; Inatomi N; Satoh H
Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
[TBL] [Abstract][Full Text] [Related]
5. Effects of lansoprazole on ethanol-induced injury and PG synthetic activity in rat gastric mucosa.
Fukuda T; Arakawa T; Shimizu Y; Ohtani K; Higuchi K; Kobayashi K
J Clin Gastroenterol; 1995; 20 Suppl 2():S5-7. PubMed ID: 7594340
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
7. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole.
Coruzzi G; Adami M; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245
[TBL] [Abstract][Full Text] [Related]
8. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
Morini G; Grandi D; Arcari ML; Bertaccini G
Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
[TBL] [Abstract][Full Text] [Related]
9. Effects of two benzimidazoles as proton pump inhibitors on water immersion stress-induced gastric ulcers in rats.
Goto H; Sugiyama S; Tsukamoto Y; Kuroiwa M; Ohara A; Hoshino H; Nakazawa S; Ozawa T
Arzneimittelforschung; 1991 Jun; 41(6):635-7. PubMed ID: 1657010
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiulcer activities of novel 2-[(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)sulfinyl]-1H- benzimidazole analogues.
Yamada S; Goto T; Shimanuki E; Narita S
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):718-20. PubMed ID: 8004722
[TBL] [Abstract][Full Text] [Related]
11. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
[TBL] [Abstract][Full Text] [Related]
12. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.
Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS
Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498
[TBL] [Abstract][Full Text] [Related]
13. Effects of the enantiomers of lansoprazole (AG-1749) on (H+ + K+)-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells.
Nagaya H; Inatomi N; Nohara A; Satoh H
Biochem Pharmacol; 1991 Oct; 42(10):1875-8. PubMed ID: 1660270
[TBL] [Abstract][Full Text] [Related]
14. Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
Bergmann JF; Chassany O; Simoneau G; Lemaire M; Segrestaa JM; Caulin C
Clin Pharmacol Ther; 1992 Oct; 52(4):413-6. PubMed ID: 1424414
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new benzimidazole derivative, NC-1300-O-3, on gastric secretion and gastroduodenal lesions in rats.
Okabe S; Akimoto Y; Yamasaki S; Kuwahara K
Jpn J Pharmacol; 1991 Apr; 55(4):477-91. PubMed ID: 1832198
[TBL] [Abstract][Full Text] [Related]
16. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of gastroprotective and antiulcer activity of some 2-substituted-1H-imidazo[4,5-b] pyridines and -1H-benzimidazoles.
Loriga M; Paglietti G; Piras S; Sparatore F; Anania V; Demontis MP; Varoni MV; Fattaccio MC
Farmaco; 1992 Mar; 47(3):287-303. PubMed ID: 1503593
[TBL] [Abstract][Full Text] [Related]
18. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effect of NC-1300-O-3 against gastric lesions induced by necrotizing agents in rats.
Matsukura H; Masuda M; Kawaguchi K; Uchida A; Kamishiro T
Jpn J Pharmacol; 1994 May; 65(1):9-18. PubMed ID: 8089937
[TBL] [Abstract][Full Text] [Related]
20. NC-1300, a proton-pump inhibitor, requires gastric acid to exert cytoprotection in rat gastric mucosa.
Arakawa T; Fukuda T; Higuchi K; Koike K; Satoh H; Kobayashi K
Jpn J Pharmacol; 1993 Apr; 61(4):299-302. PubMed ID: 8391606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
